Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 1;35(3):252-259.
doi: 10.1097/ICU.0000000000001030. Epub 2024 Jan 11.

Implementation of optical coherence tomography in retinopathy of prematurity screening

Affiliations
Review

Implementation of optical coherence tomography in retinopathy of prematurity screening

Adam M Hanif et al. Curr Opin Ophthalmol. .

Abstract

Purpose of review: In this review, we explore the investigational applications of optical coherence tomography (OCT) in retinopathy of prematurity (ROP), the insights they have delivered thus far, and key milestones for its integration into the standard of care.

Recent findings: While OCT has been widely integrated into clinical management of common retinal diseases, its use in pediatric contexts has been undermined by limitations in ergonomics, image acquisition time, and field of view. Recently, investigational handheld OCT devices have been reported with advancements including ultra-widefield view, noncontact use, and high-speed image capture permitting real-time en face visualization. These developments are compelling for OCT as a more objective alternative with reduced neonatal stress compared to indirect ophthalmoscopy and/or fundus photography as a means of classifying and monitoring ROP.

Summary: OCT may become a viable modality in management of ROP. Ongoing innovation surrounding handheld devices should aim to optimize patient comfort and image resolution in the retinal periphery. Future clinical investigations may seek to objectively characterize features of peripheral stage and explore novel biomarkers of disease activity.

PubMed Disclaimer

Conflict of interest statement

JPC receives research support from Genentech (San Francisco, CA). The i-ROP DL system has been licensed to Siloam Vision by Oregon Health & Science University, Massachusetts General Hospital, Northeastern University and the University of Illinois Chicago, which may result in royalties to JPC in the future. JPC was a consultant to Boston AI Lab (Boston, MA). JPC is an equity owner of Siloam Vision.

Figures

Figure 1:
Figure 1:
Representative ultra-widefield en face ROP fundus images obtained via prototype handheld OCT developed at Oregon Health & Science University [14, 65]. (A) Simultaneous visualization of the posterior pole and ora serrata is possible without scleral depression (yellow arrowheads). (B) Subtle features of stage at the vascular-avascular border are visible in 360 degrees.

Similar articles

Cited by

References

    1. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684–94. - PubMed
    1. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988;106(4):471–9. - PubMed
    1. Fleck BW, Williams C, Juszczak E, et al. An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials. Eye (Lond). 2018;32(1):74–80. - PMC - PubMed
    1. Gilbert C Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84(2):77–82. - PubMed
    1. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603–15. - PMC - PubMed